Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: '336-reexam - new entry in transaction history

The '584 was Forwarded to Examiner April 16 2007

The  Reexam Non-Final Action Mailed June 26 2007

The Non-Final Action, which if I am not mistaken came, directly on the heels of the Markman's finding re claim 29 of the '584, and may have actually sped that process up..

opinions... 

 

Share
New Message
Please login to post a reply